GTH's logo.
Ticker Symbol: GTH

Genetron Holdings Ltd - ADR

$13.30 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: ADR CIK:0001782594

Company Profile

Genetron Holdings Limited ("Genetron Health" or the "Company") is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products.

Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Standard Industrial Classification Code (SIC code): 8071
Address: N/A
CEO: N/A
Tags:
  • Health Services
  • Medical/Nursing Services
  • Health Care and Social Assistance
  • Medical Laboratories

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.80
Change: $0.01 ( 1.78%)
Days Range: $0.77 - $0.84
Beta: 0.19
52wk. High: $1.27
52wk. Low: $0.69
Ytd. Change -27.59%
50 Day Moving Average: $0.92
200 Day Moving Average: $0.92
Shares Outstanding: 91548706

Valuation

Market Cap: 7.4B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A